Leaflet SEVORANE 250mg volatile liquid for inhalations

Indicated for: general anesthesia; procedural sedation

Route of administration: inhalation

Substance: sevoflurane (general anesthetic)

ATC: N01AB08 (Nervous system | Anesthetics, general | Halogenated hydrocarbons)

Sevoflurane is an inhalation anesthetic agent used for the induction and maintenance of general anesthesia. It works by depressing the central nervous system, inducing a state of unconsciousness and muscle relaxation.

The medication is administered via inhalation under the supervision of an anesthesiologist, usually during surgical procedures. It is important for administration to be performed in controlled conditions to prevent complications.

Patients should be aware of potential side effects, such as nausea, vomiting, or hypotension. It is important to inform the doctor of any unusual symptoms after anesthesia.

Common side effects include nausea, vomiting, and hypotension. In rare cases, severe reactions such as malignant hyperthermia or liver failure may occur. Patients should be informed of these risks before administration.

General data about SEVORANE 250mg

  • Substance: sevoflurane
  • Date of latest medicines list: 01-12-2019
  • Product code: W65263002
  • Concentration: 250mg
  • Pharmaceutical form: volatile liquid for inhalations
  • Packing volume: 250ml
  • Product type: Original
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: AESICA QUEENBOROUGH LIMITED - MAREA BRITANIE
  • Holder: ABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIA
  • Number: 7586/2015/02
  • Shelf life: 3 years

Pharmaceutical forms available for sevoflurane

Concentrations available for sevoflurane

  • 100%
  • 250mg